Latest revenue
$39.4M
as of 2026-03-31
Latest net income
$-2.4M
as of 2026-03-31
Net margin
-6.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $376.0M
- Enterprise value
- $376.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $12.00
- 52-wk low
- $1.51
- Beta
- —
- Shares out
- 70.5M
5-year trend
What this company does
Item 1. Business Unless otherwise indicated or the context otherwise requires, references in this Annual Report on Form 10-K to the “Company,” “AirSculpt,” “we,” “us” and “our” refer to AirSculpt Technologies, Inc. and its consolidated subsidiaries and the Professional Associations (as defined hereinafter). Our Company AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. We believe our treatment results…
AI summary unavailable — showing raw filing excerpt
Generated from AIRS's filing dated 2026-03-31
Key risks
12 Table of Contents Item 1A. Risk Factors We are subject to risks and uncertainties that could cause our actual financial condition, results of operations, business and prospects to differ materially from those contemplated by the forward-looking statements contained in this report or our other filings with the SEC. Some of these risks and uncertainties are discussed below. If any of the following risks, or other risks and uncertainties, actually occurred, our business, financial condition and operating results could suffer. The following is a summary of some of these risks: Risk Factors Summary We are providing the following summary of the risk factors contained in this Annual Report on…
AI summary unavailable — showing raw filing excerpt
Generated from AIRS's filing dated 2026-03-31
Profitability
Operating margin
-7.6%
656.2%Net margin
-7.7%
68.0%Return on equity
-13.3%
27.8%Return on assets
-6.2%
58.5%Leverage
Debt / equity
1.14×
31.1%Long-term debt / equity
0.58×
30.1%Debt / assets
53.2%
14.6%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $39.4M | +0.0% | $-2.4M | +15.8% | -6.1% |
Q4 2025 2025-12-31 | $33.4M | -14.6% | $1.3M | +109.2% | 3.8% |
Q3 2025 2025-09-30 | $35.0M | -17.8% | $-9.5M | -195.7% | -27.2% |
Q2 2025 2025-06-30 | $44.0M | -13.7% | $-591.0K | -120.9% | -1.3% |
Q1 2025 2025-03-31 | $39.4M | -17.3% | $-2.8M | -147.2% | -7.2% |
Q4 2024 2024-12-31 | $39.2M | — | $-13.9M | — | -35.4% |
Q3 2024 2024-09-30 | $42.5M | -9.1% | $-3.2M | -3486.3% | -7.6% |
Q2 2024 2024-06-30 | $51.0M | -8.4% | $2.8M | +60.2% | 5.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Offices & Clinics of Doctors of Medicine · SIC 8011
Your notes
Keep private notes on AIRS — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$6.0M
Insider selling
$7.4K
Net activity
+$6.0M
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns AIRS
Institutional value
$93.8M
Total shares held
33.4M
Distinct holders
43
-45 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Vesey Street Capital Partners, L.L.C. | 30.3M | $85.8M | +0 (+0.0%) | No change |
| 2 | BlackRock, Inc. | 804.1K | $2.3M | -170.4K (-17.5%) | Trimmed |
| 3 | UBS Group AG | 622.3K | $1.8M | +496.9K (+396.4%) | Added |
| 4 | CITIZENS FINANCIAL GROUP INC/RI | 265.9K | $752.4K | +27.0K (+11.3%) | Added |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 233.6K | $661.2K | — | New |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 138.3K | $391.3K | — | New |
| 7 | CITIGROUP INC | 100.3K | $283.9K | +29.1K (+40.8%) | Added |
| 8 | GROUP ONE TRADING LLC | 92.0K | $260.2K | — | New |
| 9 | Nuveen, LLC | 90.9K | $257.2K | +59.7K (+191.4%) | Added |
| 10 | VANGUARD FIDUCIARY TRUST CO | 88.4K | $250.0K | — | New |
| 11 | JANE STREET GROUP, LLC | 82.0K | $232.1K | -280.9K (-77.4%) | Trimmed |
| 12 | SEI INVESTMENTS CO | 60.2K | $170.3K | — | New |
| 13 | HSBC HOLDINGS PLC | 46.9K | $135.5K | — | New |
| 14 | Bank of New York Mellon Corp | 36.4K | $103.0K | +0 (+0.0%) | No change |
| 15 | SRS Capital Advisors, Inc. | 29.1K | $82.4K | — | New |
| 16 | CHESAPEAKE ASSET MANAGEMENT LLC | 25.0K | $70.8K | — | New |
| 17 | Invesco Ltd. | 24.3K | $68.7K | -514 (-2.1%) | Trimmed |
| 18 | RHUMBLINE ADVISERS | 17.5K | $49.5K | -4.3K (-19.6%) | Trimmed |
| 19 | Mariner, LLC | 16.2K | $45.8K | — | New |
| 20 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 14.2K | $44.9K | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once AIRS's latest filing finishes processing.